IMAX CORP (IMAX) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:IMAX - CA45245E1097 - Common Stock
34.61 USD
-0.78 (-2.2%)
34.61 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 82% to IMAX. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 44.45. This target is 28.45% above the current price.
- IMAX was analyzed by 18 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about IMAX.
- In the previous month the buy percentage consensus was at a similar level.
- IMAX was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-15 | Macquarie | Maintains | Outperform -> Outperform |
| 2025-12-18 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-15 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2025-12-08 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-12-08 | Benchmark | Maintains | Buy -> Buy |
| 2025-12-08 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-12-08 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-11-25 | Goldman Sachs | Upgrade | Sell -> Neutral |
| 2025-10-24 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-10-24 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-10-24 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-24 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-10-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-10-14 | Roth Capital | Maintains | Buy -> Buy |
| 2025-10-09 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-10-09 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-09-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-09-22 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-09-19 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-07-25 | Benchmark | Maintains | Buy -> Buy |
| 2025-07-25 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-07-25 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-07-25 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-07-24 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-07-11 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-07-09 | Roth Capital | Reiterate | Buy -> Buy |
| 2025-06-16 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-06-13 | Roth Capital | Maintains | Buy -> Buy |
| 2025-04-25 | Macquarie | Maintains | Outperform -> Outperform |
| 2025-04-24 | Barrington Research | Maintains | Outperform -> Outperform |
IMAX CORP / IMAX FAQ
Can you provide the average price target for IMAX CORP stock?
18 analysts have analysed IMAX and the average price target is 44.46 USD. This implies a price increase of 28.45% is expected in the next year compared to the current price of 34.61.
How do analysts rate IMAX CORP (IMAX)?
The consensus rating for IMAX CORP (IMAX) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed IMAX CORP (IMAX)?
The number of analysts covering IMAX CORP (IMAX) is 18.